52205-73-9

基本信息
ESTRAMUSTINE PHOSPHATE SODIUM
-(dihydrogenphosphate),disodiumsalt
3,5(10)-triene-3,17-diol(17-beta)-estra-3-(bis(2-chloroethyl)carbamate)17
emcyt
estra-1,3,5(10)-triene-3,17-beta-diol3-(bis(2-chloroethyl)carbamate)17-disod
estracytsodium
estramustinephosphatedisodium
iumphosphate
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt
Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt
Estracyt
Estramustine phosphate disodium salt
NSC 89199
Ro 21-8837/001
Estra-1,3,5(10)-trien-3,17-diol-(17beta)-, 3-(Bis(2-chlorethyl)carbamat) 17-(Dihydrogen-phosphat), Dinatriumsalz
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol 3-(bis(2-chloroethyl)carbamate) 17-(dihydrogenphosphate) disodium salt
1,3,5(10)-Estratriene-3,17β-diol 3-[bis(2-chloroethyl)carbamate]17-[phosphoric acid disodium] salt
物理化学性质
储存条件 | Inert atmosphere,2-8°C |
溶解度 | H2O中可溶50mg/mL |
形态 | 结晶固体 |
颜色 | White to off-white |
水溶解性 | H2O: 50mg/mL |
稳定性 | 吸湿性,溶液不稳定 |
CAS 数据库 | 52205-73-9(CAS DataBase Reference) |
安全数据
危险性符号(GHS) | ![]() GHS08 |
警示词 | 危险 |
危险性描述 | H361-H351 |
防范说明 | P201-P202-P281-P308+P313-P405-P501-P201-P202-P281-P308+P313-P405-P501 |
危险品标志 | Xi |
危险类别码 | 37 |
安全说明 | 26 |
WGK Germany | 3 |
RTECS号 | KG7350000 |
海关编码 | 29242990 |
知名试剂公司产品信息
雌莫司汀磷酸钠价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2025/02/08 | HY-13627 | 雌莫司汀磷酸钠 Estramustine phosphate sodium | 52205-73-9 | 5 mg | 290元 |
2025/02/08 | HY-13627 | 雌莫司汀磷酸钠 Estramustine phosphate sodium | 52205-73-9 | 10mM * 1mLin Water | 360元 |
2025/02/08 | HY-13627 | 雌莫司汀磷酸钠 Estramustine phosphate sodium | 52205-73-9 | 10mg | 391元 |
常见问题列表
Estramustine phosphate sodium (1 µg/mL) treatment suppressed PC3 cell growth.
Estramustine phosphate sodium (2 µg/mL) treatment significantly elevates phosphatidylserine eversion amount on PC3 cells. Estramustine phosphate sodium induces PC3 cell apoptosis.
Estramustine phosphate sodium (2 µg/mL) treatment decreases MiR-31 level. Estramustine phosphate odium induces s prostate cancer cell line PC3 apoptosis through reducing miR-31.
Estramustine phosphate sodium, a unique antitumour agent, is selectively taken up by prostate cells and exerts antineoplastic effects by interfering with microtubule of dynamics and by reducing plasma levels of testosterone.
Estrone and estradiol, products of the metabolism of Estramustine phosphate sodium, have shown antigonadotrophic activity resulting in reduced testosterone levels similar to those achieved after surgical castration.
Estramustine phosphate sodium (4-12 mg/kg; intraperitoneal injection; daily; for 2 weeks) inhibits PAC120 tumor growth 53% by day 35.
Animal Model: | Swiss nu/nu (nude) male mice (5-week-old) bearing PAC120 tumors |
Dosage: | 4 mg/kg, 12 mg/kg |
Administration: | Intraperitoneal injection; daily; for 2 weeks |
Result: | Suppressed the development of skin lesions and resulted in a dissociation between DTH response and antibody production. |